Literature DB >> 19879720

Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review.

Donna M Urquhart1, Fahad S Hanna, Sharon L Brennan, Anita E Wluka, Karin Leder, Peter A Cameron, Stephen E Graves, Flavia M Cicuttini.   

Abstract

Although deep surgical site infection (SSI) is a major complication of primary total hip arthroplasty (THA), there are conflicting data regarding the incidence of deep SSI, and no comprehensive evaluation of the associated risk factors has been undertaken. We performed a systematic review of the literature; undertaking computer-aided searches of electronic databases, assessment of methodological quality, and a best-evidence synthesis. The incidence of SSI ranged from 0.2% before discharge to 1.1% for the period up to and including 5 years post surgery. Greater severity of a pre-existing illness and a longer duration of surgery were found to be independent risk factors for deep SSI. There is a need for high-quality, prospective studies to further identify modifiable risk factors for deep SSI after THA. Crown
Copyright © 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19879720     DOI: 10.1016/j.arth.2009.08.011

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  75 in total

1.  Concomitant infection and local metal reaction in patients undergoing revision of metal on metal total hip arthroplasty.

Authors:  Kyle T Judd; Nicolas Noiseux
Journal:  Iowa Orthop J       Date:  2011

Review 2.  [Septic endoprosthesis exchange : Preoperative diagnosis and reimplantation].

Authors:  H M L Mühlhofer; J Schauwecker; I J Banke; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2015-12       Impact factor: 1.087

3.  The Otto Aufranc Award: Modifiable versus nonmodifiable risk factors for infection after hip arthroplasty.

Authors:  Guy Maoz; Michael Phillips; Joseph Bosco; James Slover; Anna Stachel; Ifeoma Inneh; Richard Iorio
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

Review 4.  [Periprosthetic infections of the hip joint : Clinical approach].

Authors:  H M L Mühlhofer; H Gollwitzer; F Lenze; S Feihl; F Pohlig; R von Eisenhart-Rothe; J Schauwecker
Journal:  Orthopade       Date:  2015-05       Impact factor: 1.087

Review 5.  Periprosthetic Infection in Joint Replacement.

Authors:  Christina Otto-Lambertz; Ayla Yagdiran; Franziska Wallscheid; Peer Eysel; Norma Jung
Journal:  Dtsch Arztebl Int       Date:  2017-05-26       Impact factor: 5.594

6.  Development of a simple multidisciplinary arthroplasty wound-assessment instrument: the SMArt Wound Tool

Authors:  Sahil Singh Kooner; Brendan Sheehan; Joseph Keith Kendal; Herman Johal
Journal:  Can J Surg       Date:  2018-10-01       Impact factor: 2.089

7.  Prosthetic joint infection following hip fracture and degenerative hip disorder: a cohort study of three thousand, eight hundred and seven consecutive hip arthroplasties with a minimum follow-up of five years.

Authors:  Richard Blomfeldt; Piotr Kasina; Carin Ottosson; Anders Enocson; Lasse J Lapidus
Journal:  Int Orthop       Date:  2015-09-18       Impact factor: 3.075

8.  Is arthroplasty immediately after an infected case a risk factor for infection?

Authors:  Mansour Abolghasemian; Amir Sternheim; Alireza Shakib; Oleg A Safir; David Backstein
Journal:  Clin Orthop Relat Res       Date:  2013-02-07       Impact factor: 4.176

9.  Do claims-based comorbidities adequately capture case mix for surgical site infections?

Authors:  Hilal Maradit Kremers; Laura W Lewallen; Brian D Lahr; Tad M Mabry; James M Steckelberg; Daniel J Berry; Arlen D Hanssen; Elie F Berbari; Douglas R Osmon
Journal:  Clin Orthop Relat Res       Date:  2014-12-06       Impact factor: 4.176

10.  A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings.

Authors:  Nicholas M Bernthal; Alexandra I Stavrakis; Fabrizio Billi; John S Cho; Thomas J Kremen; Scott I Simon; Ambrose L Cheung; Gerald A Finerman; Jay R Lieberman; John S Adams; Lloyd S Miller
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.